Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, 6 Shuang-yong Road, Nanning, Guangxi Province, 530021, China.
Stem Cell Rev Rep. 2010 Dec;6(4):579-84. doi: 10.1007/s12015-010-9188-4.
It is generally believed that the invasion of hepatocellular carcinoma (HCC) into the biliary tree ultimately leads to the formation of bile duct tumor thrombi (BDTT). However, recent studies revealed that primary tumor might be small, even undetectable, and there was no histopathologic evidence of direct tumor invasion into bile duct wall in some patients. During the last decade, efforts on stem cell biology may shed light on the pathogenesis of BDTT. Presently, accumulating evidence supports the following notions: (1) the canals of Hering (CoH) are the most likely origin of liver stem/progenitor cells (LSPCs) in adult livers; (2) similar signalling pathways may regulate self-renewal in LSPCs and liver cancer cells, and a substantial proportion of liver tumors may often originate from the transformation of LSPCs; and (3) liver cancer contains rare cells with stem cell-like properties, which could derive from malignant transformation of LSPCs. Herein, we propose that HCC with BDTT, especially with small or undetectable primary lesion and/or no histopathologic evidence for bile duct invasion, might arise from LSPCs residing in the CoH and, possibly, some primary lesions are formed firstly within the intrahepatic biliary tree. When "tumor thrombi" extends mainly along bile duct, there might be "BDTT" alone; when it invades into surrounding parenchyma, there might often be small "primary tumor" with "BDTT". If this holds true, the putative type may be a particular subset of HCC, and most importantly it would facilitate our understanding of stem-cell origin of HCC.
人们普遍认为,肝细胞癌(HCC)侵犯胆管最终导致胆管癌栓(BDTT)的形成。然而,最近的研究表明,在一些患者中,原发肿瘤可能很小,甚至无法检测到,并且没有胆管壁直接肿瘤侵犯的组织病理学证据。在过去的十年中,对干细胞生物学的研究可能揭示了 BDTT 的发病机制。目前,越来越多的证据支持以下观点:(1)Hering 管(CoH)是成人肝脏中肝干细胞/祖细胞(LSPCs)的最可能来源;(2)类似的信号通路可能调节 LSPCs 和肝癌细胞的自我更新,并且相当一部分肝肿瘤可能经常起源于 LSPCs 的转化;(3)肝癌包含具有干细胞样特性的罕见细胞,这些细胞可能来源于 LSPCs 的恶性转化。在此,我们提出伴有 BDTT 的 HCC,特别是伴有小或不可检测的原发灶和/或无胆管侵犯的组织病理学证据的 HCC,可能起源于 CoH 中的 LSPCs,并且可能首先在肝内胆管内形成一些原发灶。当“肿瘤栓”主要沿胆管延伸时,可能仅有“BDTT”;当它侵犯周围实质时,通常会有伴有“BDTT”的小“原发灶”。如果这是正确的,那么这种假设的类型可能是 HCC 的一个特定亚型,最重要的是,它将有助于我们理解 HCC 的干细胞起源。